Reznik A, Karpenko O, Shumakova E, Mudrak A, Sokolov A, Nazimova S
Consort Psychiatr. 2025; 5(4):16-38.
PMID: 39980622
PMC: 11839220.
DOI: 10.17816/CP15567.
Tognin S, Catalan A, Aymerich C, Richter A, Kempton M, Modinos G
Schizophrenia (Heidelb). 2025; 11(1):23.
PMID: 39979326
PMC: 11842736.
DOI: 10.1038/s41537-025-00562-9.
Minichino A, Davies C, Karpenko O, Christodoulou N, Ramalho R, Nandha S
Mol Psychiatry. 2025; .
PMID: 39953286
DOI: 10.1038/s41380-025-02902-8.
Guo X, Zhou E, Wang X, Huang B, Gao T, Pu C
Schizophrenia (Heidelb). 2025; 11(1):11.
PMID: 39893207
PMC: 11787389.
DOI: 10.1038/s41537-025-00557-6.
Teo P, Koh E, Chong S
Malays J Med Sci. 2025; 31(6):178-193.
PMID: 39830103
PMC: 11740817.
DOI: 10.21315/mjms2024.31.6.14.
Three-year course of clinical high-risk symptoms for psychosis in the community: a latent class analysis.
Michel C, Osman N, Rinaldi G, Schimmelmann B, Kindler J, Schultze-Lutter F
Epidemiol Psychiatr Sci. 2025; 34():e3.
PMID: 39801353
PMC: 11735126.
DOI: 10.1017/S2045796024000891.
Frontal Pole Neuromodulation for Impulsivity and Suicidality in Veterans With Mild Traumatic Brain Injury and Common Co-Occurring Mental Health Conditions: Protocol for a Pilot Randomized Controlled Trial.
Bernanke A, Hasley R, Sabetfakhri N, de Wit H, Smith B, Wang L
JMIR Res Protoc. 2024; 13():e58206.
PMID: 39671573
PMC: 11681286.
DOI: 10.2196/58206.
Clinical and neurocognitive profiles of a combined clinical high risk for psychosis and clinical control sample: latent class analysis.
Stuble M, Schultze-Lutter F, Kaess M, Franscini M, Traber-Walker N, Walger P
BJPsych Open. 2024; 10(6):e226.
PMID: 39635738
PMC: 11698148.
DOI: 10.1192/bjo.2024.815.
Impact of minimal self disorders on naturalistic episodic memory in first-episode psychosis and parallels in healthy individuals with schizotypal traits.
Yeh D, Penaud S, Gaston-Bellegarde A, Scoriels L, Krebs M, Piolino P
Front Psychiatry. 2024; 15:1469390.
PMID: 39605999
PMC: 11598521.
DOI: 10.3389/fpsyt.2024.1469390.
Clinical Correlates of Antipsychotic Plasma Levels with Long-Acting Paliperidone: Corrélats cliniques des concentrations plasmiques de palipéridone à libération prolongée.
Zipursky R, Agid O, Kiang M, Remington G
Can J Psychiatry. 2024; 70(3):209-216.
PMID: 39544022
PMC: 11565505.
DOI: 10.1177/07067437241295648.
Brief ICF Core Set for Schizophrenia: Development of Criteria for Assessing the Degree of Disability.
Pinho L, Lopes M
Port J Public Health. 2024; 40(1):17-25.
PMID: 39469500
PMC: 11320071.
DOI: 10.1159/000524422.
A Comparative Analysis of Neurocognitive Function in Community- and Hospital-Based Patients With Schizophrenia.
Maeng S, Kim H, Lee T, Koo H, Kim W
Psychiatry Investig. 2024; 21(10):1110-1119.
PMID: 39465237
PMC: 11513869.
DOI: 10.30773/pi.2024.0077.
Risperidone ISM: review and update of its usefulness in all phases of schizophrenia.
Messer T, Bernardo M, Anta L, Martinez-Gonzalez J
Ther Adv Psychopharmacol. 2024; 14:20451253241280046.
PMID: 39421638
PMC: 11483852.
DOI: 10.1177/20451253241280046.
The Practical and Social Functioning (PSF) scale: development and measurement properties of an instrument for assessing activity and social participation among people with serious mental illness.
Clausen H, Ruud T
BMC Psychiatry. 2024; 24(1):693.
PMID: 39415117
PMC: 11481451.
DOI: 10.1186/s12888-024-06135-x.
Outcomes of an adapted prolonged exposure psychotherapy for people with early phase psychosis, substance misuse, and a history of adversity: the PE + trial.
Patterson V, Tibbo P, Stewart S, Town J, Crocker C, Ursuliak Z
BMC Psychiatry. 2024; 24(1):684.
PMID: 39402517
PMC: 11479562.
DOI: 10.1186/s12888-024-06050-1.
TV-46000, A Long-Acting Subcutaneous Antipsychotic Agent, Demonstrated Improved Patient-Centered Outcomes in Patients with Schizophrenia.
Citrome L, Suett M, Franzenburg K, Eshet R, Elgart A, Davis Rd G
Neuropsychiatr Dis Treat. 2024; 20:1901-1917.
PMID: 39399879
PMC: 11471067.
DOI: 10.2147/NDT.S459104.
Digital mental health intervention for schizophrenia spectrum and psychotic disorders: Protocol for a pragmatic feasibility study of Horyzons-Canada.
Lal S, Gleeson J, DAlfonso S, Lepage M, Joober R, Lee H
Digit Health. 2024; 10:20552076241282231.
PMID: 39372808
PMC: 11456180.
DOI: 10.1177/20552076241282231.
Study protocol TransTAM: Transdiagnostic research into emotional disorders and cognitive-behavioral therapy of the adaptive mind.
Hermann A, Benke C, Blecker C, de Haas B, He Y, Hofmann S
BMC Psychiatry. 2024; 24(1):657.
PMID: 39369190
PMC: 11456249.
DOI: 10.1186/s12888-024-06108-0.
Immunomodulatory treatment may change functional and structural brain imaging in severe mental disorders.
Thunberg P, Fresnais D, Hamilton P, Bejerot S, Humble M
Brain Behav Immun Health. 2024; 41:100864.
PMID: 39350952
PMC: 11439893.
DOI: 10.1016/j.bbih.2024.100864.
The role of affective temperaments in self-care and medication adherence among individuals with bipolar disorder: a moderation analysis.
Visalli G, Longobardi G, Iazzolino A, DAngelo M, Stefano V, Paribello P
Front Psychiatry. 2024; 15:1443278.
PMID: 39323967
PMC: 11422117.
DOI: 10.3389/fpsyt.2024.1443278.